J Barankiewicz
Overview
Explore the profile of J Barankiewicz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
277
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Czubak K, Grzywa T, Sidor-Dzitkowska K, Pilch Z, Bielak K, Hoser G, et al.
Br J Haematol
. 2024 Nov;
206(2):478-483.
PMID: 39567409
Multiple myeloma (MM), one of the most frequent haematological malignancies, significantly increases the risk of bacterial infections due to treatment-related side effects, comorbidities and cancer-induced immune deficiencies. Recently, CD71 erythroid...
2.
Firczuk M, Gabrysiak M, Barankiewicz J, Domagala A, Nowis D, Kujawa M, et al.
Cell Death Dis
. 2013 Jul;
4:e741.
PMID: 23887632
Glucose-regulated protein 78 (GRP78) is an endoplasmic reticulum (ER)-resident chaperone and a major regulator of the unfolded protein response (UPR). Accumulating evidence indicate that GRP78 is overexpressed in many cancer...
3.
4.
Wiesner J, Ugarkar B, Castellino A, Barankiewicz J, Dumas D, Gruber H, et al.
J Pharmacol Exp Ther
. 1999 May;
289(3):1669-77.
PMID: 10336567
Adenosine levels increase at seizure foci as part of a postulated endogenous negative feedback mechanism that controls seizure activity through activation of A1 adenosine receptors. Agents that amplify this site-...
5.
Barankiewicz J, Danks A, Marangos P
Adv Exp Med Biol
. 1998 May;
431:395-9.
PMID: 9598099
No abstract available.
6.
Barankiewicz J, Danks A, Abushanab E, Makings L, Wiemann T, Wallis R, et al.
J Pharmacol Exp Ther
. 1998 Feb;
283(3):1230-8.
PMID: 9399998
The physiological role of adenosine (Ado) is well known. Although a number of pharmacological attempts have been made to manipulate Ado concentrations in ischemic conditions in different tissues, none have...
7.
Spychala J, Mitchell B, Barankiewicz J
J Immunol
. 1997 May;
158(10):4947-52.
PMID: 9144513
Adenosine has potent immunosuppressive activity. Since the source of adenosine and the mechanism of its release in the immune system is largely unknown and may vary according to cell type,...
8.
Kossenjans W, Rymaszewski Z, Barankiewicz J, Bobst A, Ashraf M
Microcirculation
. 1996 Mar;
3(1):39-47.
PMID: 8846270
Objective: Oxidative stress from increased production of reactive oxygen species or decreased efficiency of inhibitory and scavenger systems may contribute to vascular injury. In this study, we developed an in...
9.
Baker P, Davidge S, Barankiewicz J, Roberts J
Hypertension
. 1996 Jan;
27(1):56-61.
PMID: 8591888
We propose that the dichotomy between the in vivo reduction in intravascular prostacyclin production that occurs in preeclampsia and the in vitro stimulatory effect of plasma from preeclamptic patients on...
10.
Firestein G, Bullough D, Erion M, Jimenez R, Barankiewicz J, Smith C, et al.
J Immunol
. 1995 Jan;
154(1):326-34.
PMID: 7527814
Adenosine and adenosine analogues exhibit anti-inflammatory effects in vitro and in vivo, but their usefulness is limited by profound cardiovascular side effects. Therefore, we synthesized inhibitors of an enzyme involved...